Status:
WITHDRAWN
The Role of Glutathione Deficiency and MSIDS Variables in Long COVID-19
Lead Sponsor:
University of California, Irvine
Collaborating Sponsors:
Hudson Valley Healing Arts Center
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this research study is to assess if glutathione, along with NAC (N-acetyl cysteine) and Alpha lipoic acid (ALA), can help reverse some of the COVID long-haul symptoms.Subjects will be r...
Eligibility Criteria
Inclusion
- • Patients with positive COVID testing (AB, RT PCR) and mild-severe symptoms based on COVID symptom list
Exclusion
- • History of a severe sulfa sensitivity (i.e., anaphylaxis, Stevens Johnson Syndrome), allergy to meat products and/or gelatin (alpha gal allergy) and/or a history of an allergic or adverse reaction to NAC, alpha lipoic acid and/or GSH.
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05371288
Start Date
June 1 2025
End Date
November 1 2025
Last Update
November 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Irvine Medical Center
Orange, California, United States, 92868